Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesOphthalmology/OptometryProvidence Meibomian Gland Coverage Update | OpenP…
    Ask Trek AI about this page
    CurrentProvidence Health PlanPolicy 30

    Automated Evacuation of the Meibomian Glands

    Customize your policy alerts

    Sign up for Providence Health Plan Policy 30 alerts

    Get alerted when Policy 30 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of automated meibomian gland evacuation using heat and intermittent pressure, including the LipiFlow Thermal Pulsation System, for applicable Providence commercial and Medicaid/OHP members. The service is considered not medically necessary for treatment of any condition, including meibomian gland dysfunction and dry eye disease.

    Policy Summary
    PayerProvidence Health Plan
    PolicyAutomated Evacuation of the Meibomian Glands
    Policy CodePolicy N/A
    Change TypeAdministrative annual update
    Effective DateNovember 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateOctober 1, 2027
    Key ActionObtain prior authorization for unlisted codes submitted for potentially covered services addressed by this policy.
    SourceLink
    POLICY UPDATE CHANGES

    The November 2026 annual update made no changes to the coverage criteria or coding.

    Not medically necessaryCoverage stance
    Commercial and Medicaid/OHP

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Applicable products
    10 RCTs; n=761Evidence base
    0207T + 0330TDenial edit

    Coverage Criteria

    Automated meibomian gland evacuation

    The service is considered not medically necessary.

    Not medically necessary: Automated evacuation of the meibomian glands using heat and intermittent pressure, including the LipiFlow Thermal Pulsation System, is considered not medically necessary as a treatment of any condition, including but not limited to meibomian gland dysfunction and dry eye disease.

    Applies broadly to treatment of any condition; no covered clinical exception is stated.

    Automated evacuation of the meibomian glands using heat and intermittent pressure is considered not medically necessary for treatment of any condition, including meibomian gland dysfunction and dry eye disease.

    The LipiFlow Thermal Pulsation System and comparable automated meibomian gland evacuation procedures using heat and intermittent pressure are considered not medically necessary for treatment of any condition.

    Claims for CPT 0330T billed in conjunction with CPT 0207T will be denied as not medically necessary.

    Evidence is insufficient to support the clinical utility or safety of automated meibomian gland evacuation for treatment of dry eye disease or meibomian gland dysfunction. High-quality studies are needed to establish safety, effectiveness, and superiority to standard care, such as warm compresses; no evidence-based clinical practice guidelines addressing this treatment were identified.

    CPT Coding

    CPT CodesCPT
    0207TEvacuation of meibomian glands, automated, using heat and intermittent pressure, unilateral.
    0330TTear film imaging, unilateral or bilateral, with interpretation and report.
    0563TEvacuation of meibomian glands, using heat delivered through wearable, open-eye eyelid treatment devices and manual gland expression, bilateral.

    Provider and Billing Actions

    Prior Authorization

    Prior Authorization Recommended

    For an unlisted code submitted for a potentially covered service addressed by this policy, obtain prior authorization before providing the service when possible. Prior authorization is recommended to help avoid a post-service denial.

    • Prior authorization is recommended for potentially covered unlisted services.
    Denial Risk

    Automated Evacuation Is Not Covered

    Automated evacuation of the meibomian glands using heat and intermittent pressure, including the LipiFlow® Thermal Pulsation System, is not medically necessary and is not covered for any condition.

    • Applies to meibomian gland dysfunction, dry eye disease, and other conditions.
    • Services determined not medically necessary will deny as not covered.

    Clinical Background

    The meibomian glands line the eyelid margins and secrete oil that helps prevent evaporation and drying of the ocular surface. When the glands produce insufficient or poor-quality oil, often because of obstruction, meibomian gland dysfunction may cause or worsen dry eye symptoms and eyelid inflammation. Automated evacuation applies controlled heat near the glands and intermittent pressure to facilitate lipid release.

    Key Definitions

    Meibomian gland dysfunction (MGD)
    DefinitionA disorder in which the meibomian glands do not secrete enough oil or secrete oil of poor quality, often because the glands are plugged.
    Ocular effectsMGD can cause or exacerbate dry eye symptoms and eyelid inflammation.
    Chronic obstructionChronically clogged meibomian glands can lead to permanent changes in the tear film and dry eyes.
    Automated evacuation of the meibomian glands
    Procedure settingAn in-office procedure for patients with chronic cystic conditions of the eyelids.
    Heat therapyControlled heat is applied to the inner eyelid surface near the meibomian glands.
    Policy Summary
    PayerProvidence Health Plan
    PolicyAutomated Evacuation of the Meibomian Glands
    Policy CodePolicy N/A
    Change TypeAdministrative annual update
    Effective DateNovember 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateOctober 1, 2027
    Key ActionObtain prior authorization for unlisted codes submitted for potentially covered services addressed by this policy.
    SourceLink
    On This Page
    Coverage CriteriaCPT CodingProvider and Billing ActionsClinical BackgroundKey Definitions
    Billing Rule

    Do Not Bill 0330T With 0207T

    Do not bill CPT 0330T with CPT 0207T. Claims billed with both codes will deny as not medically necessary.

    • 0207T: Evacuation of meibomian glands, automated, using heat and intermittent pressure, unilateral.
    • 0330T: Tear film imaging, unilateral or bilateral, with interpretation and report.
    Denial Risk

    Unlisted-Code Coverage and Authorization Risk

    All unlisted codes are reviewed at the claim level for medical necessity, correct coding, and pricing. An unlisted code submitted for a non-covered service addressed in this policy will deny as not covered; for a potentially covered service, prior authorization is recommended to avoid post-service denial.

    • Code-list inclusion or omission does not imply or guarantee reimbursement or coverage.
    • See the applicable non-covered and prior authorization lists on the Company Medical Policy, Reimbursement Policy, Pharmacy Policy, and Provider Information websites.
    Billing Rule

    Additional Claim-Edit Risks

    Claims remain subject to other applicable payment and coding rules, even when a code is listed in this policy. The code list is provided as a courtesy and may not be all-inclusive.

    • Provider contracts, member benefits, eligibility, and potential utilization audits apply.
    • HCPCS/CPT codes may be subject to CMS National Correct Coding Initiative procedure-to-procedure bundling edits and medically unlikely edits (MUEs). This policy does not take precedence over NCCI edits or MUEs; follow CMS coding guidance and applicable code combinations.
    • The listed codes include 0563T for bilateral evacuation of meibomian glands using heat delivered through wearable, open-eye eyelid treatment devices and manual gland expression.
    Intermittent pressureIntermittent pressure is applied to the outer eyelid to facilitate release of lipid from the cystic meibomian glands.
    Device componentsThe procedure uses a sterile, single-use eyepiece attached to a physician-controlled console that adjusts the heat and pressure delivered to the eyelid.
    LipiFlow Thermal Pulsation System intended use
    DeviceThe LipiFlow Thermal Pulsation System was cleared by the U.S. FDA in 2011 under the 510(k) premarket notification process.
    Intended therapyThe system is intended to provide localized heat and pressure therapy.
    Patient populationThe intended patient population is adults with chronic cystic conditions of the eyelids.
    Included conditionsIncluded conditions are meibomian gland dysfunction, evaporative dry eye, and lipid-deficiency dry eye.